The present invention provides an improved process for the preparation of alpha form of imatinib mesylate with (long needle) and α- crystal form (small needle) in a consistent manner and novel alpha crystal forms of imatinib mesylate. The present invention in particular provides a reproducible and efficient process. In particular the present invention provides a efficient process which gives higher yields and consistent results.